As a component of the 40S subunit, increased RPS15A expression is closely correlated with poor prognosis in gastric cancer (GC) patients and promotes epithelial-mesenchymal transition (EMT) and GC progression, as demonstrated [36]. Here, RPS15A is linked to gastric cancer.